Disclaimer:
This blog is for informational purposes only and should not be taken as medical advice. Content is sourced from third parties, and we do not guarantee accuracy or accept any liability for its use. Always consult a qualified healthcare professional for medical guidance.
Primary Peritoneal Cancer (PPC) is a rare malignancy arising in the peritoneum (abdominal/pelvic lining), similar to ovarian cancer in histology (serous carcinoma) and behavior, often grouped with ovarian/fallopian tube cancers. It spreads intraperitoneally, producing ascites. In 2025, ~7,000-8,000 US cases (often misdiagnosed as ovarian), affecting women post-menopause (median age 60).
Symptoms include abdominal bloating/distension, pain, early satiety, indigestion, nausea, constipation, urinary frequency, vaginal bleeding, and weight loss/gain from ascites. Advanced causes shortness of breath (pleural effusion). Symptoms mimic ovarian cancer or IBS.
Causes involve genetic mutations (BRCA1/2 in 10-15%, TP53), with risk factors like age, nulliparity, endometriosis, and family history of breast/ovarian cancer. No strong lifestyle links, but hormone therapy may increase risk. In 2025, peritoneal mesothelial cell transformation is key.
Diagnosis uses CA-125 blood test (elevated), imaging (CT, MRI showing omental caking/ascites), and laparoscopy/biopsy for confirmation. In 2025, ctDNA liquid biopsies aid early detection.
Treatment mirrors ovarian: cytoreductive surgery + HIPEC (heated intraperitoneal chemotherapy), systemic chemotherapy (carboplatin + paclitaxel), and targeted therapy (PARP inhibitors for BRCA+). In 2025, immunotherapy trials show 20% response.
In 2025, 5-year survival is 25-40% with optimal debulking. PARP inhibitors extend to 3 years in BRCA+. By 2030, vaccines and AI could improve to 50%.
The information is based on Cleveland Clinic’s “Primary Peritoneal Cancer: Causes, Symptoms, and Treatment” for overview; MD Anderson’s “Peritoneal cancer: 8 questions, answered” for symptoms; WebMD’s “Primary Peritoneal Cancer: Causes, Symptoms, Diagnosis, Treatment” for diagnosis; Mayo Clinic’s “Peritoneal carcinomatosis – Symptoms and causes” for causes; Cleveland Clinic’s “Get Peritoneal Cancer Treatment” for treatment; Yale Medicine’s “Peritoneal Cancer” for symptoms; Macmillan’s “Primary peritoneal cancer” for overview; UCSF Health’s “Peritoneal Cancer | Conditions” for symptoms; MedicalNewsToday’s “Primary peritoneal cancer (PPC)” for outlook.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
1. Scan at your preferred center.
2. Written report from a specialist radiologist sent via email.
3. Access and download your scan images digitally.
4. Upon request, we can send the report and images to your doctor or hospital.
5. For self-referred patients, there is an additional charge of £30, which includes scan referral and a discussion with a private GP before and after the scan